Talc Anhydrous

CHEMBL3990276 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
361.2 g/mol
LogP
Phase
4

Talc anhydrous is a dehydrated form of hydrated magnesium silicate used predominantly as a pharmaceutical excipient and dusting agent in tablet manufacturing, capsule filling, and topical formulations. It functions as a glidant and lubricant to improve powder flow properties during drug production. In medical contexts it has been investigated as a sclerosing agent for pleural diseases.

आणविक भार

361.2500 g/mol

TPSA

188.00 Ų

चिकित्सीय क्षेत्र

क्रिया का तंत्र

Causes endothelial damage and inflammation when injected into a vessel, leading to thrombosis, fibrosis, and eventual obliteration of the treated vein or vascular malformation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

Causes endothelial damage and inflammation when injected into a vessel, leading to thrombosis, fibrosis, and eventual obliteration of the treated vein or vascular malformation.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O

InChI

InChI=1S/3Mg.4O2Si.3O/c;;;4*1-3-2;;;

Molecular Formula

Mg3O11Si4

HBD / HBA

- / 11

घूर्णनीय बंधन

0

भारी परमाणु

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

Talc anhydrous is a dehydrated form of hydrated magnesium silicate used predominantly as a pharmaceutical excipient and dusting agent in tablet manufacturing, capsule filling, and topical formulations. It functions as a glidant and lubricant to improve powder flow properties during drug production. In medical contexts it has been investigated as a sclerosing agent for pleural diseases.

Causes endothelial damage and inflammation when injected into a vessel, leading to thrombosis, fibrosis, and eventual obliteration of the treated vein or vascular malformation.

Yes, Talc Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3990276. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 44134961. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.